Organization
Santen Pharmaceutical
5 clinical trials
Clinical trial
A Phase III, Randomized, Observer-Masked, Active-Controlled, Parallel-Group, Multinational and Multicenter Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution 0.002% Compared With Latanoprost Ophthalmic Solution 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension- PEONY StudyStatus: Completed, Estimated PCD: 2019-01-01
Clinical trial
An Open-Label, Long-Term Phase III Study of STN1012600 Ophthalmic Solution Alone and in Combination With Timolol Ophthalmic Solution, in Subjects With Open Angle Glaucoma or Ocular Hypertension (Angel-J2 Study)Status: Recruiting, Estimated PCD: 2024-01-31
Clinical trial
A Randomized, Double-masked, Controlled Parallel Group, Multi-center Study of DE-111A (Fixed Dose Combination of Tafluprost and Timolol Eye Drops) on the Treatment of Open Angle Glaucoma or Ocular Hypertension (With Tafluprost Eye Drops as a Comparator)Status: Completed, Estimated PCD: 2023-04-04
Clinical trial
A Phase III, Randomized, Observer-Masked, Active-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1012600 Ophthalmic Solution 0.002% Compared With Latanoprost 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (Angel-J1 Study)Status: Completed, Estimated PCD: 2023-04-18
Clinical trial
Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males VolunteersStatus: Completed, Estimated PCD: 2023-06-21